Delivery Order SPE2DB22D1202-SPE2DB24FVFZ1

Award Date 7/5/24
Potential Completion Date 7/8/24
Potential Value $3.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of the medication Junel Fe 1 mg-20 mcg tablet. The contract has a firm fixed price of $1,104.20 and an ultimate completion date of August 29, 2024. It is a delivery order contract with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,326.24 firm fixed-price delivery order covers the supply of the medication Junel FE 1 mg-20 mcg tablet, with a period of performance through February 11, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,203.45, is for the delivery of a specific pharmaceutical product, JUNEL FE 1 MG-20 MCG TABLET 28S. It is a firm fixed-price delivery order contract with an ultimate completion date of October 17, 2024. The contract does not have a set-aside designation, indicating open...
The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract worth $1,380.60 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is for the delivery of JUNEL FE 1 MG-20 MCG TABLET 28S, a pharmaceutical product, with a completion date of February 5, 2024. This order is part of a larger indefinite delivery contract (IDC) awarded solely to...
This is a federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $1,244.76, with a firm fixed price and a completion date of January 6, 2025. The contract is for the supply of a pharmaceutical product, JUNEL FE 1 MG-20 MCG Tablet 28S, to support military healthcare programs. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award is for the delivery of pharmaceutical products, specifically the medication Junel FE 1mg-20 168s, to the U.S. government. The contract, valued at $6,130.56, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Delivery Order type with a Firm Fixed Price pricing structure and has an ultimate completion date of September 23, 2024. The contract is not set-aside and...
This federal contract award, valued at $1,192.59, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of the pharmaceutical product JUNEL FE 1 MG-20 MCG TABLET 28S. The contract has an ultimate completion date of May 20, 2025 and is a Firm Fixed Price agreement. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,285.66 firm fixed price delivery order contract is for the supply of the contraceptive drug Junel FE 1 mg-20 mcg tablets. The contract has an ultimate completion date of August 2, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $1,104.48 firm fixed price delivery order is for the supply of Junel FE 1 mg-20 mcg tablets. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 2025, which serves as the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,899.04 firm fixed-price contract is for the supply of the prescription drug Junel FE 1.5 mg-30 mcg tablet, which is used for contraception. The order has an ultimate completion date of January 24, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB24FVFZ1
    Delivery Order

This contract award is for the supply of medical products, specifically the generic pharmaceutical Junel FE 1 mg-20 mcg tablets, to the Defense Logistics Agency (DLA). The contract, valued at $3,626.49, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. The contract has a completion date of July 8, 2024.

Generated 5/17/25, 10:13 AM